BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wongwarangkana C, Wanlapakorn N, Chansaenroj J, Poovorawan Y. Retinoic acid receptor beta promoter methylation and risk of cervical cancer. World J Virol 2018; 7(1): 1-9 [PMID: 29468136 DOI: 10.5501/wjv.v7.i1.1]
URL: https://www.wjgnet.com/2220-3249/full/v7/i1/1.htm
Number Citing Articles
Kheirollah Yari, Zohreh Rahimi. Promoter Methylation Status of the Retinoic Acid Receptor-Beta 2 Gene in Breast Cancer Patients: A Case Control Study and Systematic ReviewBreast Care 2019; 14(2): 117 doi: 10.1159/000489874
Sarah T.K. Sin, Yan Li, Ming Liu, Stephanie Ma, Xin-Yuan Guan. TROP-2 exhibits tumor suppressive functions in cervical cancer by dual inhibition of IGF-1R and ALK signalingGynecologic Oncology 2019; 152(1): 185 doi: 10.1016/j.ygyno.2018.10.039
Xiaoqiong Luo, Jingxi Wei, Feng-lian Yang, Xiao-xia Pang, Feng Shi, Yu-xia Wei, Bi-yun Liao, Jun-li Wang. Exosomal lncRNA HNF1A-AS1 affects cisplatin resistance in cervical cancer cells through regulating microRNA-34b/TUFT1 axisCancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-1042-4
Ramón Cacabelos. Pharmacoepigenetics2019; : 139 doi: 10.1016/B978-0-12-813939-4.00005-X